Diosuxentan is an investigational new drug that is being developed by Biocity Biopharmaceutics for the treatment of diabetic nephropathy. It is an endothelin A receptor antagonist.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.